Advertisement

Axsome Therapeutics Stock: Bear vs. Bull

Axsome Therapeutics Stock: Bear vs. Bull

With shares of Axsome Therapeutics (NASDAQ: AXSM) skyrocketing 87% so far this year, the biotech's shareholders are doubtlessly pleased. Thanks to a pair of newly approved products, growth is finally on the way -- with revenue set to go from practically $0 to more than $100 million in the course of a year.